Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment

BACKGROUND. Bevacizumab, a monoclonal antibody targeting a vascular endothelial growth factor (VEGF) protein, has been reported to induce mucosal toxicities. However, the clinical characteristics of these particular toxicities have not been well characterized. We aimed at providing a detailed clinic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Gavrilovic, Igor T., Balagula, Yevgeniy, Rosen, Alyx C., Ramaswamy, Vijay, Dickler, Maura N., Dunkel, Ira J., Lacouture, Mario E.
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2012
Fag:
Symptom Management and Supportive Care
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286177/
https://ncbi.nlm.nih.gov/pubmed/22282905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0198
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker